Two woman conversing over coffee in a cafe

Schizophrenia is a complex mental health condition that affects how people think, feel, and behave. Treatment can help people with schizophrenia engage in school or work, achieve independence, and enjoy personal relationships. Despite common misconceptions, schizophrenia is indeed treatable, with coordinated specialty care transforming the outlook for young people in the early stages of schizophrenia and promoting recovery while encouraging participation in work and school.

Modern treatment approaches have evolved significantly, with coordinated specialty care (CSC) becoming known as a multi-element, recovery-oriented, and patient-centered approach to treating early psychosis. The combination of evidence-based medication management and psychosocial interventions offers the best outcomes for individuals with schizophrenia, helping them lead fulfilling lives and maintain their independence.

Table of Contents

  • Schizophrenia Medication
  • Therapy for Schizophrenia
  • Inpatient Treatment for Schizophrenia
  • Early Intervention Programs
  • What to Do If a Loved One Has Schizophrenia
  • Frequently Asked Questions
  • How Therapy Can Help / Find a Therapist
  • References

Schizophrenia Medication

Antipsychotic Medications: The Foundation of Treatment

The American Psychiatric Association recommends that patients with schizophrenia be treated with an antipsychotic medication and monitored for effectiveness and side effects. These medications remain the cornerstone of schizophrenia treatment, working by affecting neurotransmitters such as dopamine and serotonin in the brain.

Types of Antipsychotic Medications

There are two main categories of antipsychotic medications:

First-Generation (Typical) Antipsychotics:

  • Thorazine (chlorpromazine)
  • Prolixin (fluphenazine)
  • Haldol (haloperidol)
  • Trilafon (perphenazine)

These older medications can be effective but have a higher risk of movement-related side effects.

Second-Generation (Atypical) Antipsychotics:

  • Abilify (aripiprazole)
  • Clozaril (clozapine)
  • Risperdal (risperidone)
  • Zyprexa (olanzapine)
  • Seroquel (quetiapine)

Research shows that at the end of treatment, CBT combined with these medications demonstrates small to medium effects on general and positive symptoms.

Special Considerations for Treatment-Resistant Schizophrenia

The American Psychiatric Association recommends that patients with treatment-resistant schizophrenia be treated with clozapine. Additionally, clozapine, the only drug approved for treatment-resistant schizophrenia, is underutilized in the United States, particularly among African American communities due to provider bias, lack of trust in the mental health care system, and overprescribing of first-generation antipsychotics.

Long-Acting Injectable Medications

Patients may receive treatment with a long-acting injectable antipsychotic medication if they prefer such treatment or if they have a history of poor or uncertain adherence. Recent developments include INVEGA HAFYERA, an every-six-month injection approved for schizophrenia treatment in adults.

Therapy for Schizophrenia

Cognitive Behavioral Therapy for Psychosis (CBTp)

Cognitive behavioral therapy has emerged as a crucial component of schizophrenia treatment. The American Psychiatric Association recommends that patients with schizophrenia be treated with cognitive-behavioral therapy for psychosis (CBTp).

Recent research provides important insights into CBTp effectiveness:

  • A 2024 umbrella review found suggestive evidence in favor of CBT for general psychopathology, delusions, and hallucinations at the end of treatment
  • Meta-analysis showed small-to-medium effects of CBTp for psychotic symptoms, with increasing effectiveness over time, particularly for delusions
  • Systematic reviews concluded that both CBT and cognitive remediation therapy (CRT) are effective in reducing the burden of negative symptoms

Family Therapy and Interventions

The American Psychiatric Association suggests that patients with schizophrenia who have ongoing contact with family receive family interventions. The evidence for family therapy is particularly strong:

  • Psychoeducational family management programs have shown a significant reduction in relapse when compared to standard psychiatric care from 49% to 13%
  • At least 50 randomized controlled trials have been published showing the effectiveness of family interventions in various culturally diverse countries
  • Recent research confirms that brief multifamily programs consisting of six sessions over 1.5 months were effective in improving outcomes for caregivers and preventing relapse in patients
  • A 2022 meta-analysis of 90 randomized controlled trials found that nearly all types of family interventions significantly reduced relapse at 12 months, with basic family psychoeducation associated with the lowest relapse rates

Psychoeducation

The American Psychiatric Association recommends that patients with schizophrenia receive psychoeducation. This intervention helps individuals and their families understand the condition, recognize symptoms, and develop coping strategies. Studies show psychoeducation reduces caregiver burden, decreases depression, and increases knowledge about schizophrenia.

Supported Employment Services

The American Psychiatric Association recommends that patients with schizophrenia receive supported employment services. These programs help individuals find and maintain competitive employment, which is crucial for recovery and social integration.

Assertive Community Treatment (ACT)

The American Psychiatric Association recommends that patients with schizophrenia receive assertive community treatment if there is a history of poor engagement with services leading to frequent relapse or social disruption. ACT teams provide intensive, community-based support to help individuals maintain stability and avoid hospitalization.

Inpatient Treatment for Schizophrenia

Hospitalization may be necessary during severe episodes of schizophrenia. The primary goal of inpatient treatment is to stabilize acute symptoms and ensure safety while developing an appropriate treatment plan.

When Hospitalization May Be Needed:

  • First episode of psychosis requiring diagnosis and treatment initiation
  • Severe symptoms that pose a risk to self or others
  • Inability to care for oneself due to symptom severity
  • Need for medication adjustment under close supervision

Studies estimate that between 15 and 100 people out of 100,000 develop psychosis each year, presenting many opportunities for early intervention. During hospitalization, the treatment team conducts comprehensive assessments, initiates or adjusts medications, and develops a discharge plan with appropriate community supports.

Involuntary Hospitalization

In some cases, involuntary hospitalization may be necessary when an individual is unable to recognize their need for treatment and poses a danger to themselves or others. The results from a 2023 meta-analysis contribute to debunking the myth that schizophrenia inevitably has a deteriorating course, showing that recovery is certainly possible. State laws determine the specific criteria for involuntary hospitalization, typically requiring evidence of imminent danger.

Early Intervention Programs

The Importance of Early Treatment

With conditions like diabetes or cancer, the sooner people get into care, the better they do—the same is true of psychotic illness. Upwards of 80 studies from early psychosis clinics show that patients see a greater reduction of symptoms and greater improvement in functioning compared to those who get usual treatment.

Coordinated Specialty Care (CSC)

CSC is a multi-element, recovery-oriented, and patient-centered approach emphasizing easy access to care and shared decision-making among a team of specialists who work with the patient and their family to create an individualized treatment plan.

Key components of CSC include:

  • Case management
  • Family support and education
  • Psychotherapy
  • Medication management
  • Supported employment and education services
  • Peer support

Evidence for Early Intervention Success

The American Psychiatric Association recommends that patients with schizophrenia who are experiencing a first episode of psychosis be treated in a coordinated specialty care program. Research demonstrates compelling outcomes:

  • NAVIGATE patients remained in treatment longer, experienced greater improvement in quality of life and psychopathology, and experienced greater involvement in work and school compared to traditional care
  • PREP participants have 50% fewer hospitalizations and demonstrate significant reductions in schizophrenia symptoms, with hospitalizations consistently reduced during the first three months and continuing to decrease over time
  • In 2023, there were more than 360 CSC programs in the United States, up from just two states in 2008

What to Do If a Loved One Has Schizophrenia

Supporting someone with schizophrenia can be challenging, but your involvement can make a significant difference in their recovery journey. Here are evidence-based strategies for helping your loved one:

Communication Tips:

  • Talk to the person the same way you would talk to anyone else
  • Avoid telling someone to "just stop listening" to hallucinations—it's not that simple
  • Be patient when the person appears disinterested; this may be a symptom rather than a choice
  • Respect their experiences while gently encouraging treatment when appropriate

Supporting Treatment:

  • Be present during and after hospitalizations, as the transition home can be particularly difficult
  • Help develop systems for medication adherence without constant reminders
  • Encourage participation in therapy and support groups
  • Learn about the condition through family psychoeducation programs

Managing Your Own Well-being:

  • High levels of expressed emotion (criticism, hostility, or emotional over-involvement) have been consistently linked to poorer treatment outcomes and increased severity of psychiatric symptoms
  • Consider joining a family support group or seeking your own therapy to manage stress
  • Set realistic expectations and celebrate small improvements
  • Take breaks when needed to prevent caregiver burnout

Understanding Treatment Refusal:

It's important to recognize that you cannot force someone to accept treatment unless they meet criteria for involuntary hospitalization. Only 10-20% of young adults experiencing psychosis gain access to the comprehensive treatment recommended by the National Institute of Mental Health. If your loved one refuses treatment:

  • Continue expressing concern and support without being confrontational
  • Educate yourself about local mental health laws and crisis services
  • Document concerning behaviors in case emergency intervention becomes necessary
  • Maintain hope—many people eventually accept help when approached with patience and understanding

Frequently Asked Questions

What are the most effective treatments for schizophrenia currently available?

Cognitive remediation, metacognitive training, social skills training, psychoeducation, family interventions, cognitive behavioral therapy, physical exercise and lifestyle interventions, and supported employment can be fully considered as evidence-based treatments in schizophrenia spectrum disorders. The most effective approach combines antipsychotic medications with comprehensive psychosocial interventions delivered through coordinated specialty care programs.

How long does schizophrenia treatment typically last?

The American Psychiatric Association recommends that patients whose symptoms have improved with an antipsychotic medication continue to be treated with an antipsychotic medication. Treatment for schizophrenia is typically long-term, with many individuals requiring ongoing support throughout their lives. However, recovery is certainly possible, despite schizophrenia remaining a severe and complex mental disorder.

What should I do if traditional medications aren't working?

For treatment-resistant schizophrenia, clozapine is recommended, and it's also recommended if the risk for suicide attempts or suicide remains substantial despite other treatments. Additionally, newer treatments are emerging, with the Accelerating Medicines Partnership Schizophrenia program working to develop early interventions and improve quality of life by reducing symptom burden.

Can people with schizophrenia work or go to school?

Absolutely. Treatment can help people with schizophrenia engage in school or work, achieve independence, and enjoy personal relationships. Supported employment services are recommended as part of comprehensive treatment, and many individuals successfully maintain careers and complete their education with appropriate support.

How important is family involvement in treatment?

Family involvement is crucial for optimal outcomes. The family is the primary caregiver for most patients with schizophrenia, and their roles are essential in patients' illness trajectories and outcomes. Research shows that family interventions can simplify and standardize care while reducing relapse rates when families have access to evidence-based treatment.

What are the latest advances in schizophrenia treatment?

Recent advances include:

  • Development of new medications with fewer side effects, including LYBALVI (combining olanzapine with samidorphan to reduce weight gain)
  • Growing interest in videoconference-delivered CBT, which has been demonstrated to be equally effective as face-to-face therapy
  • Digital therapeutics receiving FDA breakthrough device designation
  • The AMP Schizophrenia program establishing an international research network focused on young people at clinical high risk, with a better understanding of how psychosis develops leading to more effective clinical trials

How Therapy Can Help / Find a Therapist

Therapy plays a vital role in schizophrenia recovery. Research suggests that the effectiveness of CBT on general and positive symptoms in schizophrenia at end of treatment is small to medium, while inconsistent evidence exists for sustainable effects. However, when combined with medication and other supports, therapy can significantly improve quality of life.

If you or a loved one is living with schizophrenia, finding the right therapist is an important step toward recovery. Look for mental health professionals who:

  • Have specific training in treating psychotic disorders
  • Offer evidence-based approaches like CBTp or family therapy
  • Work collaboratively with psychiatrists and other treatment providers
  • Understand the importance of coordinated care

[Find a therapist who specializes in schizophrenia treatment through the GoodTherapy directory]

Remember, recovery is certainly possible, and schizophrenia does not inevitably have a deteriorating course. With comprehensive treatment including medication, therapy, and community support, many people with schizophrenia lead fulfilling, productive lives.

References:

  1. American Psychiatric Association. (2020). The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (3rd ed.). American Psychiatric Association Publishing. https://doi.org/10.1176/appi.ajp.2020.177901
  2. Berendsen, S., Berendse, S., van der Torren, J., Vermeulen, J., & de Haan, L. (2024). Cognitive behavioural therapy for the treatment of schizophrenia spectrum disorders: An umbrella review of meta-analyses of randomised controlled trials. eClinicalMedicine, 67, 102392. https://doi.org/10.1016/j.eclinm.2023.102392
  3. Borghesi, L., et al. (2024). Comparing interventions for early psychosis: A systematic review and component network meta-analysis. eClinicalMedicine, 70, 102537. https://doi.org/10.1016/j.eclinm.2024.102537
  4. Foundation for the National Institutes of Health (FNIH). (2024). Accelerating Medicines Partnership® (AMP®) Schizophrenia Program. Available at: https://fnih.org/our-programs/accelerating-medicines-partnership-amp/amp-schizophrenia/
  5. Girdhar, S., et al. (2024). Understanding the Dynamics: A Comprehensive Review of Family Therapy's Impact on Expressed Emotions in Schizophrenia Patients. Cureus, 16(5), e60318. https://doi.org/10.7759/cureus.60318
  6. Gordon, J. A. (2024). From Breakthroughs to Best Practices: How NIMH Transforms Research Into Real-World Care. National Institute of Mental Health. Available at: https://www.nimh.nih.gov/about/director/messages/2024/from-breakthroughs-to-best-practices-how-nimh-transforms-research-into-real-world-care
  7. Hansen, H., Sabe, M., Floris, H., Speyer, H., Hjorthøj, C., & Nordentoft, M. (2023). The prognosis of schizophrenia: A systematic review and meta-analysis with meta-regression of 20-year follow-up studies. Schizophrenia Research, 250, 152-163. https://doi.org/10.1016/j.schres.2022.11.010
  8. Katsushima, M., et al. (2025). Effectiveness of a Videoconference-Based Cognitive Behavioral Therapy Program for Patients with Schizophrenia: Pilot Randomized Controlled Trial. JMIR Formative Research, 9(1), e59540. https://doi.org/10.2196/59540
  9. Kim, H. S., et al. (2023). Effectiveness of family interventions for patients with schizophrenia: A systematic review and meta-analysis. International Journal of Mental Health Nursing, 32, 1598-1615. https://doi.org/10.1111/inm.13198
  10. Mount Sinai Hospital. (2024). Global Schizophrenia Research Program Enters New Chapter. Reports Mount Sinai. Available at: https://reports.mountsinai.org/article/psych2024-06-amp-schizophrenia
  11. National Alliance on Mental Illness (NAMI). (2023). Early Psychosis Intervention. Available at: https://www.nami.org/Blogs/NAMI-Blog/May-2023/Early-Psychosis-Intervention
  12. National Institute of Mental Health (NIMH). (2023). 2023 Strategic Plan Progress Report. Available at: https://www.nimh.nih.gov/about/strategic-planning-reports/progress/2023-strategic-plan-progress-report
  13. National Institute of Mental Health (NIMH). (2023). RAISE-ing the Standard of Care for Schizophrenia: The Rapid Adoption of Coordinated Specialty Care in the United States. Available at: https://www.nimh.nih.gov/news/science-updates/2023/raise-ing-the-standard-of-care-for-schizophrenia
  14. National Institute of Mental Health (NIMH). (2024). Schizophrenia. Available at: https://www.nimh.nih.gov/health/topics/schizophrenia
  15. National Public Radio (NPR). (2024). Early intervention for schizophrenia is effective, but insurance won't cover it. Available at: https://www.npr.org/sections/health-shots/2024/01/02/1221097477/early-intervention-for-schizophrenia
  16. National Council for Mental Wellbeing. (2023). Early Intervention Treatments for Psychosis. Available at: https://www.thenationalcouncil.org/program/early-intervention-treatments-for-psychosis/
  17. Ortiz, B. B., Eden, A. S., de Souza, A. S. R., Teciano, C. A., de Lima, D., Noto, C.,... & Correll, C. U. (2023). A systematic review and meta-analysis of the association between psychopathology and social functioning in schizophrenia. Schizophrenia Bulletin, 49(6), 1470-1485. https://doi.org/10.1093/schbul/sbad075
  18. Ortiz, M. T. (2024). Editorial: Reviews in psychiatry 2023: schizophrenia. Frontiers in Psychiatry, 15, 1427593. https://doi.org/10.3389/fpsyt.2024.1427593
  19. Rajanna, S., et al. (2024). Comparative Effectiveness of Cognitive Behavioral Therapies in Schizophrenia and Schizoaffective Disorder: A Systematic Review and Meta-Regression Analysis. Journal of Clinical Medicine, 13(15), 5521. https://doi.org/10.3390/jcm14155521
  20. Rodolico, A., et al. (2022). Family interventions for relapse prevention in schizophrenia: A systematic review and network meta-analysis. The Lancet Psychiatry, 9(3), 211-224. https://doi.org/10.1016/S2215-0366(21)00437-5
  21. Substance Abuse and Mental Health Services Administration (SAMHSA). (2024). Treatment for Adults With Schizophrenia: A Systematic Review. Agency for Healthcare Research and Quality (AHRQ). Available at: https://www.samhsa.gov/resource/ebp/treatment-adults-schizophrenia-systematic-review
  22. Tessier, A., Roger, K., Gregoire, C., Desnavailles, P., & Misdrahi, D. (2023). Family psychoeducation to improve outcome in caregivers and patients with schizophrenia: A randomized clinical trial. Frontiers in Psychiatry, 14, 1171661. https://doi.org/10.3389/fpsyt.2023.1171661
  23. Torrent, A., et al. (2024). Evidence-based psychosocial interventions in schizophrenia: A critical review. Current Opinion in Psychiatry, 37(3), 131-142. https://doi.org/10.1097/YCO.0000000000000925
  24. van Dee, V., Schnack, H. G., & Cahn, W. (2023). Systematic review and meta-analysis on predictors of prognosis in patients with schizophrenia spectrum disorders: An overview of current evidence and a call for prospective research and open access to datasets. Schizophrenia Research, 254, 133-142. https://doi.org/10.1016/j.schres.2023.02.024
  25. Weiss, A., Chaudhry, S., Marhefka, A., & Khunkhun, V. (2024). Early Intervention in the Treatment of Psychosis. Child and Adolescent Psychiatric Clinics of North America, 33(4), 645-658. https://doi.org/10.1016/j.chc.2024.07.001
  26. Xu, F., & Xu, S. (2024). Cognitive-behavioral therapy for negative symptoms of schizophrenia: A systematic review and meta-analysis. Medicine, 103(36), e39572. https://doi.org/10.1097/MD.0000000000039572
  27. Wood, L., & Alsawy, S. (2020). Meta-analysis and Meta-regression of Cognitive Behavioral Therapy for Psychosis (CBTp) Across Time: The Effectiveness of CBTp has Improved for Delusions. Schizophrenia Bulletin Open, 1(1), sgaa023. https://doi.org/10.1093/schizbullopen/sgaa023
  28. Yuan, M., et al. (2024). Schizophrenia and type 2 diabetes risk: A systematic review and meta-analysis. Frontiers in Endocrinology, 15, 1395771. https://doi.org/10.3389/fendo.2024.1395771